Search Grant Opportunities

DoD Peer Reviewed Medical, Technology/Therapeutic Development Award

ID: HT942524PRMRPTTDA • Type: Posted

Description

The PRMRP Technology/Therapeutic Development Award (TTDA) is a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, for a disease or condition related to one of the FY24 PRMRP Topic Areas and one of the FY24 PRMRP Strategic Goals. Products in development should be responsive to the health care needs of military Service Members, Veterans, and their Families. The product(s) to be developed under the PRMRP TTDA mechanism may be a tangible item, such as a pharmacologic agent (drugs or biologics) or device, or a knowledge-based product. (A knowledge product is a non-materiel product that addresses an identified need in a topic area, is based on current evidence and research, aims to transition into medical practice, training, tools, or to support materiel solutions [systems to develop, acquire, provide, and sustain medical solutions and capabilities], and educates or impacts behavior throughout the continuum of care, including primary prevention of negative outcomes.)

The Technology/Therapeutic Development Award is not intended for basic research. Applicants generating preliminary data, basic research, performing high-risk/high-gain studies should consider one of the other FY24 PRMRP program announcements being offered. For information about these award mechanisms, see Section II.A.1, FY24 PRMRP Research Development Pipeline.

Background
The PRMRP Technology/Therapeutic Development Award (TTDA) is a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, for a disease or condition related to one of the FY24 PRMRP Topic Areas and one of the FY24 PRMRP Strategic Goals.
The vision of the PRMRP is to improve the health, care, and well-being of all military Service Members, Veterans, and their Families.

Grant Details
The U.S. Army Medical Research Acquisition Activity (USAMRAA) is soliciting applications to the fiscal year 2024 (FY24) Peer Reviewed Medical Research Program (PRMRP) using delegated authority provided by United States Code, Title 10, Section 4001 (10 USC 4001).
The Technology/Therapeutic Development Award is not intended for basic research.
The award mechanisms are aligned to different phases of the research development pipeline including Basic Research phase, Translational Research phase, and Clinical Trials/Clinical Research phase.
The Technology/Therapeutic Development Award will only support research in the final stages of preclinical development.
The anticipated direct costs budgeted for the entire period of performance for an FY24 PRMRP Technology/Therapeutic Development Award should not exceed $4.0M.

Eligibility Requirements
Extramural and Intramural organizations are eligible to apply.

Period of Performance
The period of performance for awards made under this program announcement will be no later than September 30, 2025.
Funds to be obligated on any award resulting from this funding opportunity will be available for use until September 30, 2030.

Grant Value
$90.0M is expected to be allotted to fund approximately 15 FY24 PRMRP Technology/Therapeutic Development Award applications with an anticipated direct cost budget not exceeding $4.0M.

Overview

Category of Funding
Science and Technology and other Research and Development
Funding Instruments
Cooperative Agreement
Grant
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 3/26/24 U.S. Army Medical Research Acquisition Activity posted grant opportunity HT942524PRMRPTTDA for DoD Peer Reviewed Medical, Technology/Therapeutic Development Award with funding of $90.0 million. The grant will be issued under grant program 12.420 Military Medical Research and Development. It is expected that 15 total grants will be made.

Timing

Posted Date
March 26, 2024, 12:00 a.m. EDT
Closing Date
June 6, 2024, 12:00 a.m. EDT Due in 43 Days
Last Updated
March 26, 2024, 1:48 p.m. EDT
Version
1
Archive Date
July 6, 2024

Eligibility

Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Award Sizing

Ceiling
Not Listed
Floor
Not Listed
Estimated Program Funding
$90,000,000
Estimated Number of Grants
15

Contacts

Contact
Christopher L Baker Grants Officer
Contact Email
Email Description
CDMRP Help Desk
Contact Phone
(301) 619-2332

Documents

Posted documents for HT942524PRMRPTTDA

Potential Applicants and Partners

Awardees that have recently won grants similar to HT942524PRMRPTTDA

Incumbent or Similar Grants

Grants similar to HT942524PRMRPTTDA

Similar Active Opportunities

Open grant opportunities similar to HT942524PRMRPTTDA